News

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine
(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 ...
Novavax shares surge on FDA vaccine approval
Investors reacted positively to the news, as the FDA’s approval not only enhances Novavax’s product offering but also solidifies its partnership with Sanofi, a key player in the vaccine market. The ...
EL PAÍS English48m
Tuberculosis cases on the rise in the US: How to protect yourself and everything you need to know
Currently, several states have outbreaks. In Kansas City, where cases have increased 148%, two deaths have been reported ...
WHO opens annual assembly as UN health agency faces ‘existential crisis’ in wake of US funding cuts
The World Health Organization on Monday opened its annual meeting of government ministers and other top envoys facing one of the most serious crises of its 77-year history in the ...